Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 3/20 | 0.59 |
| ▸ | ATM | Q13315 | 1/20 | 0.55 |
| ▸ | NAAA | Q02083 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 5/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.50 |
| ▸ | FAAH | O00519 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | RAD52 | P43351 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1888897 | 1.00 | HCAR2 (0.59) | HCAR2ATMNAAATSHRHPGD | |
| SCHEMBL11259256 | 1.00 | HCAR2 (0.59) | HCAR2ATMNAAATSHRHPGD | |
| SCHEMBL8815436 | 1.00 | HCAR2 (0.59) | HCAR2ATMNAAATSHRHPGD | |
| SCHEMBL11257102 | 1.00 | HCAR2 (0.59) | HCAR2ATMNAAATSHRHPGD | |
| SCHEMBL2485450 | 0.96 | ATM (0.61) | HCAR2ATMNAAATSHRHPGD | |
| SCHEMBL4740627 | 0.96 | ATM (0.61) | HCAR2ATMNAAATSHRHPGD | |
| SCHEMBL6931235 | 0.96 | HCAR2 (0.59) | HCAR2ATMNAAATSHRHPGD | |
| SCHEMBL3772230 | 0.94 | HCAR2 (0.58) | HCAR2ATMNAAATSHRHPGD | |
| SCHEMBL131584 | 0.94 | ATM (0.63) | HCAR2ATMNAAATSHRHPGD | |
| SCHEMBL8896661 | 0.92 | HCAR2 (0.59) | HCAR2ATMNAAATSHRHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110546141-B | Benzotriazole derivative compound | 希普洛化成股份有限公司 | 2023-03-28 | — | — | CN | disclosed |
| US-10919868-B2 | Benzotriazole derivative compound | SHIPRO KASEI KAISHA, LTD. (JP) | 2021-02-16 | — | — | US | disclosed |
| US-10781187-B2 | Benzotriazole derivative compound | SHIPRO KASEI KAISHI, LTD. (JP) | 2020-09-22 | — | — | US | disclosed |
| US-20200290981-A1 | BENZOTRIAZOLE DERIVATIVE COMPOUND | SHIPRO KASEI KAISHA, LTD. (JP) | 2020-09-17 | — | — | US | disclosed |
| US-20200157059-A1 | BENZOTRIAZOLE DERIVATIVE COMPOUND | SHIPRO KASEI KAISHA, LTD. (JP) | 2020-05-21 | — | — | US | disclosed |
| CN-110546141-A | Benzotriazole derivative compound | SHIPRO KASEI KAISHA LTD | 2019-12-06 | — | — | CN | disclosed |
| EP-1370614-B1 | THE USE OF AROMATIC COMPOUNDS AS PHASE DIRECTORS AND PARTICLE SIZE REDUCERS FOR QUINACRIDONE PIGMENTS | CIBA SC HOLDING AG (CH) | 2007-04-11 | — | — | EP | disclosed |
| US-6706215-B1 | 2-(2'-HYDROXYPHENYL)-1,3-PYRIMIDINE DERIVATIVE | CIBA SPECIALTY CHEMICALS CORPORATION | 2004-03-16 | — | — | US | disclosed |
| EP-1370614-A1 | THE USE OF AROMATIC COMPOUNDS AS PHASE DIRECTORS AND PARTICLE SIZE REDUCERS FOR QUINACRIDONE PIGMENTS | Ciba SC Holding AG (CH) | 2003-12-17 | — | — | EP | disclosed |
| US-6626990-B2 | Using aromatic- or heteraromatic-compounds having at least one hydroxyl or keto group bonded to the ring, with the oxidation of corresponding dihydroquinacridone salts | CIBA SPECIALTY CHEMICALS CORPORATION | 2003-09-30 | — | — | US | disclosed |
| US-20020161232-A1 | Use of aromatic compounds as phase directors and particle size reducers for quinacridone pigments | CIBA SPECIALTY CHEMICALS CORP. | 2002-10-31 | — | — | US | disclosed |
| WO-2002077104-A1 | THE USE OF AROMATIC COMPOUNDS AS PHASE DIRECTORS AND PARTICLE SIZE REDUCERS FOR QUINACRIDONE PIGMENTS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2002-10-03 | — | — | WO | disclosed |
| US-6060543-A | STABILIZE ORGANIC MATERIAL AGAINST DAMAGE BY LIGHT, OXYGEN AND/OR HEAT | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2000-05-09 | — | — | US | disclosed |
| US-5753729-A | COATING COMPOSITION COMPRISING ORGANIC POLYMER BINDER, 2-(2*-HYDROXYPHENYL)PYRIMIDINE STABILIZER | CIBA SPECIALTY CHEMICALS CORPORATION | 1998-05-19 | — | — | US | disclosed |
| US-5686233-A | PHOTOGRAPHIC FILM STABILIZER | CIBA-GEIGY CORPORATION (US) | 1997-11-11 | — | — | US | disclosed |
| US-5668200-A | Stabilizer combination | CIBA-GEIGY CORPORATION (US) | 1997-09-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200157059-A1 | BENZOTRIAZOLE DERIVATIVE COMPOUND | CCNT2, CCNT1, SULT1A1 | HCAR2 1483/4885ATM 692/4885NAAA 1292/4885 |
| US-20020161232-A1 | Use of aromatic compounds as phase directors and particle size reducers for quinacridone pigments | QDPR, POLR2H, POLR2E | HCAR2 1437/4885ATM 3135/4885NAAA 4296/4885 |
| US-20200290981-A1 | BENZOTRIAZOLE DERIVATIVE COMPOUND | CCNT2, CCNT1, SULT1A1 | HCAR2 1554/4885ATM 703/4885NAAA 1399/4885 |
| US-10781187-B2 | Benzotriazole derivative compound | CCNT2, CCNT1, SULT1A1 | HCAR2 1403/4885ATM 696/4885NAAA 1204/4885 |
| US-10919868-B2 | Benzotriazole derivative compound | CCNT2, CCNT1, SULT1A1 | HCAR2 1554/4885ATM 703/4885NAAA 1399/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.